The Food and Drug Administration (FDA) is announcing the revocation of the biologics license (U.S. License No. 0916) issued to CHEMBIOMED, LTD. (CHEMBIOMED) for the manufacture of Anti-A (Murine Monoclonal), Anti-B (Murine Monoclonal), Anti-Le\a\ (Murine Monoclonal) and Anti-Le\b\ (Murine Monoclonal). CHEMBIOMED did not respond to a notice of opportunity for a hearing on a proposal to revoke its license.
Document
CHEMBIOMED, LTD.; Revocation of U.S. License No. 0916
The Food and Drug Administration (FDA) is announcing the revocation of the biologics license (U.S. License No. 0916) issued to CHEMBIOMED, LTD. (CHEMBIOMED) for the manufacture ...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 38696
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“CHEMBIOMED, LTD.; Revocation of U.S. License No. 0916,” thefederalregister.org (July 7, 2015), https://thefederalregister.org/documents/2015-16562/chembiomed-ltd-revocation-of-u-s-license-no-0916.